Table 2.
qPCR | Flow cytometry | |
---|---|---|
Assay sensitivity 9 |
Highly sensitive: LLOQ ≤ 50 copies of transgene/µg DNA |
Sensitivity depends on the relative affinity of the CAR/TCR detection agent, i.e., anti‐ID vs. dextramer |
Sample matrix and storage 46 , 47 | Frozen whole blood | Whole blood at room temperature, run 24–72 hours for absolute cell quantitation |
Sample batching 46 , 47 | Yes | No, must be analyzed within 1–2 days post collection to enable absolute cell quantitation |
Detection 47 | Measures copies of transgene in the cell | Measures cells with surface expression of transgenic CAR/TCR, multiplexed with other markers of T‐cell phenotype/subset |
Post‐treatment detection duration 8 | Can often detect transgene in circulation for years depending on cell persistence | Generally, can detect engineered T‐cells in circulation for months to years, but may fall below assay sensitivity at later time points depending on cell persistence |
Other considerations |
The extent of transgene incorporation into genome is generally unknown. Does not measure expression level of the transgenic CAR/TCR on the cell surface. Applying newly developed qPCR method with volume‐based unit enables more accurate evaluation of in vivo ACT kinetics due to reduced bias from processes such as lymphodepletion 11 |
Does not provide direct quantitation of the extent/density of CAR/TCR expression on the cell surface. CAR/TCR downregulation upon T cell activation may lower the mean fluorescence intensity without affecting the cell count |
ACT, adoptive cell therapy; anti‐ID, anti‐idiotype; CAR, chimeric antigen receptor; LLOQ, lower limit of quantification; qPCR, quantitative polymerase chain reaction; TCR, T cell receptor.